A follow up study of patients with paraneoplastic neurological disease in the United Kingdom

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 10, 2004, Pages 1411-1415

  Candler, P M ^b   Hart, P E ^b   Barnett, M ^b   Weil, R ^b   Rees, J H ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN G; STEROID;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY DETECTION; BREAST CANCER; CEREBELLUM DEGENERATION; DISEASE ASSOCIATION; ENCEPHALOMYELITIS; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOMODULATION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; OVARY CANCER; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SEX RATIO; SURVIVAL TIME; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASMS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS; RADIOPHARMACEUTICALS; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4644220396     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.025171     Document Type: Review

References (20)

1. Elrington GM, Murray NM, Spiro SG, et al. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol Neurosurg Psychiatry 1991;54:764-7.
2. Posner JB. Paraneoplastic Syndromes. Neurological Complications of Cancer. Philadelphia: FA Davies, 1995:353-85.
3. Sillevis SP, Grefkens J, de Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002;249:745-53.
4. Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992;71:59-72.
5. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(Pt 7):1481-94.
6. Peterson K, Rosenblum MK, Kotanides H, et al. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992;42:1931-7.
7. Graus F, Keime-Guibert F, Rene R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124(Pt 6):1138-48.
8. Rees JH, Hain SF, Johnson MR, et al. The role of [(18)F]fluoro-2- deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 2001;124(Pt 11):2223-31.
9. Dalmau J, Furneoux HM, Gralla RJ, et al. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 1990;27:544-52.
10. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988;24:559-67.
11. Luque FA, Furneaux HM, Ferziger R, et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol 1991;29:241-51.
12. Voltz R, Gultekin SH, Rosenfeld MR, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999;340:1788-95.
13. Sutton IJ, Fursdon Davis G, Esiri MM, et al. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus. Ann Neurol 2001;49:253-7.
14. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988;38:1391-8.
15. Croft PB, Henson RA, Urich H, et al. Sensory neuropathy with bronchial carcinoma: a study of four cases showing serological abnormalities. Brain 1965;88:501-14.
16. Stourac P, Kadanka Z, Palyza V. Paraneoplastic neurological syndromes - patients' cohort profile in the Czech Republic. Acta Neurol Scand 2001;104:72-7.
17. Faris M, Abraham J, Barrett-Lee P. A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: response to CMF chemotherapy. Clin Oncol (R Coll Radiol) 1998;10:202-3.
18. Suzuki M, Kimura H, Tachibona I, et al. Improvement of anti-Hu-associated paraneoplastic sensory neuropathy after chemoradiotherapy in a small cell lung cancer patient. Intern Med 2001;40:1140-3.
19. de la Sayette V, Bertran F, Honnorat J, et al. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. Arch Neurol 1998;55:405-8.
20. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003;126(Pt 6):1409-18.